Current Research Pertaining to the Correlation of Prion Proteins and Alzheimer's Disease
Main Article Content
Abstract
At present, there are around 50 million AD patients worldwide and this number is projected to double every 5 years and will increase to reach 152 million by 2050. (National Library of Medicine). This neurodegenerative disease has been known to cause cognitive impairment and memory loss. In recent research ti seems that this degenerative disease is being correlated with the accumulation of the amyloid-beta (Aß) peptide as well as the prion protein ( P r C ) . (PrPC) has been discovered to have inhibitory properties on the Beta-Secretase enzyme (BACE1). The inhibition of BACE1 leads to the essential deprivation of the rate-limiting step, which results in the increase of amyloid-beta.
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.